ブデソニドの世界市場2020-2026:鼻スプレー、吸入器、ピル&直腸フォーム

QYResearchが発行した調査報告書(QYR20AP00403)
◆英語タイトル:Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00403
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ブデソニドの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ブデソニドのグローバル市場動向、メーカー別競争状況、種類別市場規模(鼻スプレー、吸入器、ピル&直腸フォーム)、用途別市場規模(呼吸器疾患の治療、鼻疾患の治療、炎症性腸疾患の治療)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ブデソニドの種類別市場2015-2026:鼻スプレー、吸入器、ピル&直腸フォーム
・ブデソニドの用途別市場2015-2026:呼吸器疾患の治療、鼻疾患の治療、炎症性腸疾患の治療
・ブデソニドの北米市場分析
・ブデソニドのアジア市場分析
・ブデソニドの中南米市場分析
・ブデソニドの中東・アフリカ市場分析
・関連企業情報:AstraZeneca、Cosmo Pharmaceuticals、Teva、Mylan、Sandoz、Dr. Falk Pharma、Chiesi Farmaceutici S.p.A、Orion Corporation、Cipla、Synmosa Biopharma Corporation、Lunan Better Pharmaceutical、Shanghai Sine Promod Pharmaceutical
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn’s disease, ulcerative colitis and microscopic colitis.Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.
North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
In 2019, the global Budesonide market size was US$ 3241.3 million and is forecast to US$ 5515.2 million in 2026, growing at a CAGR of 7.8% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Budesonide.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Budesonide market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Budesonide market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Budesonide market. Readers of the report can become informed about current and future trends of the global Budesonide market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Budesonide markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Budesonide market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Budesonide market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Budesonide market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Budesonide market is segmented into
Nasal Spray
Inhaler
Pill&Rectal Forms

Market Segment by Application, the Budesonide market is segmented into
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

This report includes the following manufacturers; we can also add the other companies as you want.
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

The study objectives are:
To analyze and research the global Budesonide status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Budesonide manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Budesonide are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Budesonide Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Budesonide Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Nasal Spray
1.3.3 Inhaler
1.3.4 Pill&Rectal Forms
1.4 Market Segment by Application
1.4.1 Global Budesonide Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Respiratory Disease Treatment
1.4.3 Nose Disease Treatment
1.4.4 Inflammatory Bowel Disease Treatment
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Budesonide Revenue (2015-2026)
2.1.1 Global Budesonide Revenue (2015-2026)
2.1.2 Global Budesonide Sales (2015-2026)
2.2 Budesonide Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Budesonide Sales by Regions (2015-2020)
2.2.2 Global Budesonide Revenue by Regions (2015-2020)
2.3 Global Top Budesonide Regions (Countries) Ranking by Market Size
2.4 Budesonide Industry Trends
2.4.1 Budesonide Market Top Trends
2.4.2 Market Drivers
2.4.3 Budesonide Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Budesonide Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Budesonide Manufacturers by Sales (2015-2020)
3.1.1 Global Budesonide Sales by Manufacturers (2015-2020)
3.1.2 Global Budesonide Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Budesonide Sales in 2019
3.2 Global Top Manufacturers Budesonide by Revenue
3.2.1 Global Budesonide Revenue by Manufacturers (2015-2020)
3.2.2 Global Budesonide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Budesonide Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2019)
3.4 Global Budesonide Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Budesonide Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Budesonide Market
3.7 Key Manufacturers Budesonide Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Budesonide Historic Market Review by Type (2015-2020)
4.1.2 Global Budesonide Sales Market Share by Type (2015-2020)
4.1.3 Global Budesonide Revenue Market Share by Type (2015-2020)
4.1.4 Budesonide Price by Type (2015-2020)
4.1 Global Budesonide Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Budesonide Sales Forecast by Type (2021-2026)
4.2.3 Global Budesonide Revenue Forecast by Type (2021-2026)
4.2.4 Budesonide Price Forecast by Type (2021-2026)

5 Global Budesonide Market Size by Application
5.1 Global Budesonide Historic Market Review by Application (2015-2020)
5.1.2 Global Budesonide Sales Market Share by Application (2015-2020)
5.1.3 Global Budesonide Revenue Market Share by Application (2015-2020)
5.1.4 Budesonide Price by Application (2015-2020)
5.2 Global Budesonide Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Budesonide Sales Forecast by Application (2021-2026)
5.2.3 Global Budesonide Revenue Forecast by Application (2021-2026)
5.2.4 Budesonide Price Forecast by Application (2021-2026)

6 North America
6.1 North America Budesonide Breakdown Data by Company
6.2 North America Budesonide Breakdown Data by Type
6.3 North America Budesonide Breakdown Data by Application
6.4 North America Budesonide Breakdown Data by Countries
6.4.1 North America Budesonide Sales by Countries
6.4.2 North America Budesonide Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Budesonide Breakdown Data by Company
7.2 Europe Budesonide Breakdown Data by Type
7.3 Europe Budesonide Breakdown Data by Application
7.4 Europe Budesonide Breakdown Data by Countries
7.4.1 Europe Budesonide Sales by Countries
7.4.2 Europe Budesonide Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Budesonide Breakdown Data by Company
8.2 Asia Pacific Budesonide Breakdown Data by Type
8.3 Asia Pacific Budesonide Breakdown Data by Application
8.4 Asia Pacific Budesonide Breakdown Data by Regions
8.4.1 Asia Pacific Budesonide Sales by Regions
8.4.2 Asia Pacific Budesonide Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Budesonide Breakdown Data by Company
9.2 Latin America Budesonide Breakdown Data by Type
9.3 Latin America Budesonide Breakdown Data by Application
9.4 Latin America Budesonide Breakdown Data by Countries
9.4.1 Latin America Budesonide Sales by Countries
9.4.2 Latin America Budesonide Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Budesonide Breakdown Data by Type
10.2 Middle East and Africa Budesonide Breakdown Data by Application
10.3 Middle East and Africa Budesonide Breakdown Data by Countries
10.3.1 Middle East and Africa Budesonide Sales by Countries
10.3.2 Middle East and Africa Budesonide Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AstraZeneca Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AstraZeneca Budesonide Products and Services
11.1.5 AstraZeneca SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Cosmo Pharmaceuticals
11.2.1 Cosmo Pharmaceuticals Corporation Information
11.2.2 Cosmo Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Cosmo Pharmaceuticals Budesonide Products and Services
11.2.5 Cosmo Pharmaceuticals SWOT Analysis
11.2.6 Cosmo Pharmaceuticals Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Teva Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Teva Budesonide Products and Services
11.3.5 Teva SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Mylan Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Mylan Budesonide Products and Services
11.4.5 Mylan SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 Sandoz
11.5.1 Sandoz Corporation Information
11.5.2 Sandoz Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Sandoz Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Sandoz Budesonide Products and Services
11.5.5 Sandoz SWOT Analysis
11.5.6 Sandoz Recent Developments
11.6 Dr. Falk Pharma
11.6.1 Dr. Falk Pharma Corporation Information
11.6.2 Dr. Falk Pharma Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Dr. Falk Pharma Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Dr. Falk Pharma Budesonide Products and Services
11.6.5 Dr. Falk Pharma SWOT Analysis
11.6.6 Dr. Falk Pharma Recent Developments
11.7 Chiesi Farmaceutici S.p.A
11.7.1 Chiesi Farmaceutici S.p.A Corporation Information
11.7.2 Chiesi Farmaceutici S.p.A Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Chiesi Farmaceutici S.p.A Budesonide Products and Services
11.7.5 Chiesi Farmaceutici S.p.A SWOT Analysis
11.7.6 Chiesi Farmaceutici S.p.A Recent Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Corporation Information
11.8.2 Orion Corporation Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Orion Corporation Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Orion Corporation Budesonide Products and Services
11.8.5 Orion Corporation SWOT Analysis
11.8.6 Orion Corporation Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Cipla Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Cipla Budesonide Products and Services
11.9.5 Cipla SWOT Analysis
11.9.6 Cipla Recent Developments
11.10 Synmosa Biopharma Corporation
11.10.1 Synmosa Biopharma Corporation Corporation Information
11.10.2 Synmosa Biopharma Corporation Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Synmosa Biopharma Corporation Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Synmosa Biopharma Corporation Budesonide Products and Services
11.10.5 Synmosa Biopharma Corporation SWOT Analysis
11.10.6 Synmosa Biopharma Corporation Recent Developments
11.11 Lunan Better Pharmaceutical
11.11.1 Lunan Better Pharmaceutical Corporation Information
11.11.2 Lunan Better Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Lunan Better Pharmaceutical Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Lunan Better Pharmaceutical Budesonide Products and Services
11.11.5 Lunan Better Pharmaceutical SWOT Analysis
11.11.6 Lunan Better Pharmaceutical Recent Developments
11.12 Shanghai Sine Promod Pharmaceutical
11.12.1 Shanghai Sine Promod Pharmaceutical Corporation Information
11.12.2 Shanghai Sine Promod Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Shanghai Sine Promod Pharmaceutical Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Shanghai Sine Promod Pharmaceutical Budesonide Products and Services
11.12.5 Shanghai Sine Promod Pharmaceutical SWOT Analysis
11.12.6 Shanghai Sine Promod Pharmaceutical Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Budesonide Sales Channels
12.2.2 Budesonide Distributors
12.3 Budesonide Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Budesonide Sales Forecast (2021-2026)
13.1.1 Global Budesonide Sales Forecast by Regions (2021-2026)
13.1.2 Global Budesonide Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Budesonide Sales Forecast (2021-2026)
13.2.2 North America Budesonide Revenue Forecast (2021-2026)
13.2.3 North America Budesonide Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Budesonide Sales Forecast (2021-2026)
13.3.2 Europe Budesonide Revenue Forecast (2021-2026)
13.3.3 Europe Budesonide Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Budesonide Sales Forecast (2021-2026)
13.4.2 Asia Pacific Budesonide Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Budesonide Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Budesonide Sales Forecast (2021-2026)
13.5.2 Latin America Budesonide Revenue Forecast (2021-2026)
13.5.3 Latin America Budesonide Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Budesonide Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Budesonide Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Budesonide Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

AstraZeneca、Cosmo Pharmaceuticals、Teva、Mylan、Sandoz、Dr. Falk Pharma、Chiesi Farmaceutici S.p.A、Orion Corporation、Cipla、Synmosa Biopharma Corporation、Lunan Better Pharmaceutical、Shanghai Sine Promod Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ブデソニドの世界市場2020-2026:鼻スプレー、吸入器、ピル&直腸フォーム(Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。